Replies to post #773484 on NorthWest Biotherapeutics Inc (NWBO)

[RobotDroid]

The inept silence as the wait goes way too long and the stock drops like a rock, thankfully, forced me to sell half of my nwbo position and buy gns at .74. Sold at a large profit at 1.25, bought back in at $1.11, now sitting on another large profit. Linda asshat does not know a damn thing about how to work with SH or press releases. All the excuses about silence are BS, she is hiding some very bad news.

[manibiotech]

And yesterday or  today would have been last day to PR 30 day notice to schedule ASM 13 months from the last one as last ASM was June 29 . Agree something just doesn't smell right . They need to give an update , plain and simple . Market or new investors are not buying "trust us , we got this " attitude. 

[underpar71]

Yeah, I'm not sure. Sucks to sit and watch it drop, and potentially see another dilution as the cause with no updates.

[dennisdave]

If DennisDave's assumption is right, and MHRA is waiting on this new ECA guidance, then comments wrapping up today means that it will be discussed internally for a month or two before being rolled out probably another month or two after that. If that's what we're waiting on, we're looking at Sept/Oct decision. If that's not what we're waiting on, we're looking at rejection

Then it's probably not a great time to tell you that the MHRA has postponed the deadline for public comments by two weeks:
https://www.gov.uk/government/consultations/mhra-draft-guideline-on-the-use-of-external-control-arms-based-on-real-world-data-to-support-regulatory-decisions

We invite feedback on the clarity and wording of our new draft guideline on the use of external control arms based on real-world data to support regulatory decisions. This consultation closes at 11:59pm on 14 July 2025.

I regret every penny I ever invested in this POS. It's not because the stock price is tanking — it's because of the immense risk this stock carries.. But now that I'm in, I'll wait until the MHRA decides. And I don’t believe it will take months after July 14. The MHRA has already finalized the guidelines and is likely processing the relevant feedback as it comes in. That said, I really don’t like the two-week extension.

This was always a high-risk stock gamble because Powers submitted a Marketing Authorization Application based on regulatory assumptions, not on existing MHRA guidelines. What we're seeing now, including the drop in market cap, reflects that exact risk (alongside an overpaid and underperforming management team). Over the years, posters have obsessively hyped the science (with constant references to the JAMA article) — which is fine. But almost no one talked about the enormous regulatory risk of submitting an application without a clear regulatory framework in place. So what you see is what you get. Non-revenue biotech is already risky — but submitting an application without an established regulatory framework makes that risk 10x higher than with most other biotech stocks.

On a more positive note: if the MHRA really had no intention of approving DCVax-L, they would have likely issued a rejection months ago. And they certainly wouldn’t have initiated a new ECA/RWD guideline in the middle of the process. And thats why Im waiting for MHRA descion

.

[Doc logic]

FeMike,

Funny that you are such a practical thinker now during the summer months. I guess if everyone did what you are saying you will do the price might actually drop below your target because you and everyone else knows NWBO will continue to need financing along with any added selling pressure from a strategy like this. I think 350,000,000 shares sold could do that pretty quickly.
So your strategy is to allow the shares you don’t sell to be diluted for the sake of hoping to increase the number of shares you do sell by buying back at half price which should more than balance out your personal dilution rate by increasing your share count by around 11% after any fees or other expenses if all goes as planned and the price finally appreciates after that. Very practical especially if someone wants to jump the line with accumulation before buying pressure returns; ). Best wishes.

[Investor082]

ATL & Zivic posted a couple of days ago, so I don't blame you for selling. The stock is guaranteed to go down in the coming days and weeks. And as I have been saying for many months, UK approval is not expected until mid to late Q3 at the earliest (certainly not in July). That too if we are lucky!